U.S. Physical Therapy (USPH) Set to Announce Earnings on Tuesday

U.S. Physical Therapy (NYSE:USPH) will be posting its quarterly earnings results after the market closes on Tuesday, May 7th. Analysts expect U.S. Physical Therapy to post earnings of $0.58 per share for the quarter. Investors interested in registering for the company’s conference call can do so using this link.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Wednesday, February 28th. The company reported $0.59 earnings per share for the quarter, beating analysts’ consensus estimates of $0.57 by $0.02. U.S. Physical Therapy had a return on equity of 8.52% and a net margin of 4.67%. The business had revenue of $154.80 million for the quarter, compared to analysts’ expectations of $150.24 million. During the same quarter in the prior year, the business earned $0.58 EPS. The firm’s revenue for the quarter was up 9.6% on a year-over-year basis. On average, analysts expect U.S. Physical Therapy to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

U.S. Physical Therapy Trading Up 1.5 %

USPH stock opened at $105.20 on Monday. The stock has a market cap of $1.59 billion, a price-to-earnings ratio of 77.93, a price-to-earnings-growth ratio of 4.99 and a beta of 1.39. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.28 and a quick ratio of 2.28. The company has a fifty day moving average price of $105.10 and a two-hundred day moving average price of $96.06. U.S. Physical Therapy has a one year low of $78.08 and a one year high of $124.11.

U.S. Physical Therapy Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, April 5th. Investors of record on Tuesday, March 12th were paid a $0.44 dividend. The ex-dividend date was Monday, March 11th. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.43. This represents a $1.76 annualized dividend and a yield of 1.67%. U.S. Physical Therapy’s payout ratio is 130.37%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Monday, March 18th. Barrington Research lifted their price target on shares of U.S. Physical Therapy from $120.00 to $122.00 and gave the company an “outperform” rating in a research report on Friday, March 1st. Finally, JPMorgan Chase & Co. increased their price target on U.S. Physical Therapy from $99.00 to $117.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 13th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $125.67.

Insider Activity

In related news, Director Edward L. Kuntz sold 2,500 shares of the stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $104.26, for a total transaction of $260,650.00. Following the sale, the director now owns 5,780 shares in the company, valued at approximately $602,622.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, COO Graham D. Reeve sold 2,629 shares of the business’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $104.39, for a total transaction of $274,441.31. Following the completion of the transaction, the chief operating officer now owns 6,902 shares of the company’s stock, valued at approximately $720,499.78. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Edward L. Kuntz sold 2,500 shares of the firm’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $104.26, for a total value of $260,650.00. Following the completion of the sale, the director now directly owns 5,780 shares in the company, valued at $602,622.80. The disclosure for this sale can be found here. In the last ninety days, insiders sold 10,829 shares of company stock worth $1,141,535. 1.70% of the stock is currently owned by corporate insiders.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.